Asia-Pacific,
November 2021
PharmaBoardroom’s latest report, InFigures: Asia Pacific 2021 features up-to-date datasets from the region’s leading pharma markets and regional innovation hubs.
Featured markets include Asia-Pacific’s largest of PR China, Japan, South Korea, and Australia, as well as smaller but incredibly important innovation, financial, and logistical hubs such as Taiwan, Singapore, and Hong Kong.
PharmaBoardroom’s latest report, InFigures: Asia Pacific 2021 features up-to-date datasets from the region’s leading pharma markets and regional innovation hubs.
Featured markets include Asia-Pacific’s largest of PR China, Japan, South Korea, and Australia, as well as smaller but incredibly important innovation, financial, and logistical hubs such as Taiwan, Singapore, and Hong Kong.
